期刊
FRONTIERS IN PHARMACOLOGY
卷 13, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.964793
关键词
colorectal cancer (CRC); gut microbiota; natural products; tumorigenesis; immunotherapy
资金
- National Nature Science Foundation of China (China) [81874206, 82104466]
- Shanghai Frontiers Science Center of Disease and Syndrome Biology of Inflammatory Cancer Transformation (China) [2021KJ0312]
- Shanghai Rising-Star Program (China) [20QA1409300]
- Program for Young Eastern Scholar at Shanghai Institutions of Higher Learning [QD2019034]
Colorectal cancer is a common malignant carcinoma that often lacks obvious symptoms, leading to most patients being diagnosed in the middle or advanced stages of the disease. Inflammatory bowel disease and the inflammatory-cancer transformation of colorectal adenoma are the main causes of colorectal cancer. Recent research progress has revealed the important role of gut microbiota in colorectal tumorigenesis and treatment. The regulation of gut microbiota by natural products shows potential for the prevention and treatment of colorectal cancer.
Colorectal cancer (CRC) is one of the most common malignant carcinomas. CRC is characterized by asymptomatic onset, and most patients are already in the middle and advanced stages of disease when they are diagnosed. Inflammatory bowel disease (IBD) and the inflammatory-cancer transformation of advanced colorectal adenoma are the main causes of CRC. There is an urgent need for effective prevention and intervention strategies for CRC. In recent years, rapid research progress has increased our understanding of gut microbiota. Meanwhile, with the deepening of research on the pathogenesis of colorectal cancer, gut microbiota has been confirmed to play a direct role in the occurrence and treatment of colorectal cancer. Strategies to regulate the gut microbiota have potential value for application in the prevention and treatment of CRC. Regulation of gut microbiota is one of the important ways for natural products to exert pharmacological effects, especially in the treatment of metabolic diseases and tumours. This review summarizes the role of gut microbiota in colorectal tumorigenesis and the mechanism by which natural products reduce tumorigenesis and improve therapeutic response. We point out that the regulation of gut microbiota by natural products may serve as a potential means of treatment and prevention of CRC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据